Anti-MDA5 Dermatomyositis with RP-ILD and CMV Reactivation: A Case Report
References
- HENDREN E, VİNİK O, FARAGALLA H, HAQ R. Breast cancer and dermatomyositis: a case study and literature review. Curr Oncol. 2017;24(5):e429.
- NOMBEL A, FABİEN N, COUTANT F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol. 2021;12:773352.
- ALLENBACH Y, UZUNHAN Y, TOQUET S, LEROUX G, GALLAY L, MARQUET A, et al. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. Neurology. 2020;95(1):e70–e8.
- KANG DC, GOPALKRİSHNAN RV, WU Q, JANKOWSKY E, PYLE AM, FİSHER PB. MDA-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U S A. 2002;99(2):637–42.
Language: English
Submitted on: Jan 21, 2026
Published on: Mar 31, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Ömer Atakan Soğur, Dilara Bulut Gokten, Ridvan Mercan, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.